Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 11 Jun 2024

NOD2 activation enhances macrophage Fcγ receptor function and may increase the efficacy of antibody therapy

in Cancer Immunity and Immunotherapy

Giovanna Merchand-Reyes
Mikayla F. Bull
Ramasamy Santhanam
Maria L. Valencia-Pena
Rakesh A. Murugesan
Aadesh Chordia
Xiaokui-Molly Mo
Frank H. Robledo-Avila
Juan De Dios Ruiz-Rosado
William Edgar Carson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409333

3,844 views
4 citations

Review

Published on 11 Jun 2024

Immune checkpoint inhibitors in colorectal cancer: limitation and challenges

in Cancer Immunity and Immunotherapy

Suying Yan
Wanting Wang
Zhiqiang Feng
Jun Xue
Weizheng Liang
Xueliang Wu
Zhiquan Tan
Xipeng Zhang
Shuai Zhang
Xichuan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403533

8,807 views
16 citations

Original Research

Published on 11 Jun 2024

T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Chaobo Chen
Zheng Chen
Zheyu Zhou
Hui Ye
Shaohui Xiong
Weidong Hu
Zipeng Xu
Chen Ge
Chunlong Zhao
Decai Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1424752

6,741 views
6 citations

Correction

Published on 11 Jun 2024

Corrigendum: Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies

in Cancer Immunity and Immunotherapy

Nicholas J. Shields
Estelle M. Peyroux
Angela L. Ferguson
Megan Steain
Silke Neumann
Sarah L. Young

Frontiers in Immunology

doi 10.3389/fimmu.2024.1430460

1,244 views

Original Research

Published on 11 Jun 2024

The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation

in Cancer Immunity and Immunotherapy

Jun-Hui Yu
Hao-Bo Yuan
Zi-Yi Yan
Xia Zhang
Hui-Hui Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421778

2,315 views
2 citations

Review

Published on 11 Jun 2024

Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies

in Cancer Immunity and Immunotherapy

Wanyao Wang
Minglu Ding
Qiuhong Wang
Yidan Song
Keyuan Huo
Xiaojie Chen
Zihan Xiang
Lantao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404974

3,437 views
1 citation

Original Research

Published on 10 Jun 2024

PD-L1 has a heterogeneous and dynamic expression in gastric cancer with implications for immunoPET

in Cancer Immunity and Immunotherapy

Dina Ibrahim
Cristina Simó
Emma L. Brown
Shayla Shmuel
Sandeep Surendra Panikar
Alex Benton
Rachel DeWeerd
Farrokh Dehdashti
Haeseong Park
Patrícia M. R. Pereira

Frontiers in Immunology

doi 10.3389/fimmu.2024.1405485

3,290 views
3 citations

Systematic Review

Published on 10 Jun 2024

Prognostic significance of programmed cell death ligand 1 blood markers in non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Ningning Zhang
Jianlan Chang
Ping Liu
Xiangyang Tian
Junyan Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400262

2,673 views
3 citations

Original Research

Published on 10 Jun 2024

Partial hepatectomy accelerates colorectal metastasis by priming an inflammatory premetastatic niche in the liver

in Cancer Immunity and Immunotherapy

Jost Luenstedt
Fabian Hoping
Reinhild Feuerstein
Bernhard Mauerer
Christopher Berlin
Julian Rapp
Lisa Marx
Wilfried Reichardt
Dominik von Elverfeldt
Dietrich Alexander Ruess

Frontiers in Immunology

doi 10.3389/fimmu.2024.1388272

3,863 views
1 citation

Original Research

Published on 10 Jun 2024

Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics

in Cancer Immunity and Immunotherapy

Kedar A. Patwardhan
Harish RaviPrakash
Nikolaos Nikolaou
Ignacio Gonzalez-García
José Domingo Salazar
Paul Metcalfe
Joachim Reischl

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383644

2,364 views
1 citation

Review

Published on 10 Jun 2024

Regulation of anti-tumor immunity by metal ion in the tumor microenvironment

in Cancer Immunity and Immunotherapy

Yaoxin Gao
Shasha Liu
Yifan Huang
Feng Li
Yi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379365

3,302 views
5 citations

Original Research

Published on 10 Jun 2024

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events

in Cancer Immunity and Immunotherapy

Elias A. T. Koch
Anne Petzold
Edgar Dippel
Michael Erdmann
Anja Gesierich
Ralf Gutzmer
Jessica C. Hassel
Sebastian Haferkamp
Katharina C. Kähler
Nicole Kreuzberg

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395225

2,783 views
1 citation

Case Report

Published on 10 Jun 2024

Secondary adrenocortical insufficiency after treatment with retifanlimab: a case report

in Cancer Immunity and Immunotherapy

Wenjing Zhang
Li Xiao
Guangxin Zhou
Huijuan Zhu
Yongmin Bi
Junjie Du
Da Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1371527

1,810 views
1 citation

Original Research

Published on 10 Jun 2024

Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma

in Cancer Immunity and Immunotherapy

Doris K. Hansen
Binod Dhakal
Mehdi Hamadani
David Dingli
Tania Jain
Carol Ann Huff
Murali Janakiram
Yi-Hsuan Liu
Kevin C. De Braganca
Nicole Lodowski

Frontiers in Immunology

doi 10.3389/fimmu.2024.1405452

5,052 views
2 citations

Review

Published on 07 Jun 2024

CAR-T cell therapy in advanced thyroid cancer: from basic to clinical

in Cancer Immunity and Immunotherapy

Zhenhua Sun
Chaohui Wang
Yuyang Zhao
Qingyi Ling

Frontiers in Immunology

doi 10.3389/fimmu.2024.1411300

5,058 views
4 citations

Original Research

Published on 07 Jun 2024

Efficacy and safety of PD-1 inhibitors plus chemotherapy with or without endostatin for stage IV lung squamous cancer: a retrospective study

in Cancer Immunity and Immunotherapy

Chengliu Lv
Yahua Wu
Weiwei Gu
Bin Du
Na Yao
Yingjiao Zhu
Jianping Zheng
Yaping Hong
Jinhuo Lai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1413204

1,372 views